While high calpain-2 and low CAST expression was associated with improved survival in patients with non-inflammatory breast cancer treated with neoadjuvant chemotherapy, high calpain-1 and high CAST expression in the inflammatory group was associated with improved breast cancer survival (Storr et al., 2016). Here, CAPN2 is linked to breast carcinoma.